Calsona, Mia Monique A.

HRN: 28-42-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
METRONIDAZOLE 500MG (TAB)
02/26/2026
03/04/2026
PO
500 Mg
TID
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: